Planned mega-projects on rise Vancouver Sun ... but a significant number of mega-projects being proposed offer hope for growth, according to the provincial Major Projects Inventory. As of June 30, ... |
Saturday, September 11, 2010
Planned mega-projects on rise - Vancouver Sun
http://www.propertymarketservice.co.uk/link_directory/authors/author-183.html
Thursday, September 9, 2010
Greif raises earnings target as profit jumps - Business First of Columbus:
http://www.linkpaq.com/index.php?s=D&c=503
The Delaware-based industrial packager after the markets close Wednesday reported earnings for the quartet ended July 31totaling $64.6 million, up nearly a thirde from $48.8 million, or 82 cents a in the same period last year. Both this year’e and last year’s third quarters include more than $6 milliobn in restructuring charges. Fiscal third-quarter revenue grew 19 percen tto $1.03 billion from $874.2 million as the company’as largest segment, industrial packaging, posted a 21 percenft sales surge at $852.4 million. The company’s year-to-date profit was up 71 percentyat $173.9 million, or $2.95 a versus $101.4 million, or $1.
72 a in the first nine months of fiscao 2007. Revenue year-to-date was up 15 percentt at $2.8 billion, versus $2.43 billion a year ago. Anothetr quarter of strong performanceand higher-than-expected profit margins in the industrial packaging segmentf led the company to boosy full-year share earnings expectations to a rangew between $4.45 and up from a range of $4.25 and $4.45 after the close of the secondf quarter. Greif (NYSE:GEF) last year earned $2.66 a share. The company finishefd its fiscal 2007with $156.4 million in profi t on $3.32 billion in Greif employs about 10,3009 worldwide.
The Delaware-based industrial packager after the markets close Wednesday reported earnings for the quartet ended July 31totaling $64.6 million, up nearly a thirde from $48.8 million, or 82 cents a in the same period last year. Both this year’e and last year’s third quarters include more than $6 milliobn in restructuring charges. Fiscal third-quarter revenue grew 19 percen tto $1.03 billion from $874.2 million as the company’as largest segment, industrial packaging, posted a 21 percenft sales surge at $852.4 million. The company’s year-to-date profit was up 71 percentyat $173.9 million, or $2.95 a versus $101.4 million, or $1.
72 a in the first nine months of fiscao 2007. Revenue year-to-date was up 15 percentt at $2.8 billion, versus $2.43 billion a year ago. Anothetr quarter of strong performanceand higher-than-expected profit margins in the industrial packaging segmentf led the company to boosy full-year share earnings expectations to a rangew between $4.45 and up from a range of $4.25 and $4.45 after the close of the secondf quarter. Greif (NYSE:GEF) last year earned $2.66 a share. The company finishefd its fiscal 2007with $156.4 million in profi t on $3.32 billion in Greif employs about 10,3009 worldwide.
Wednesday, September 8, 2010
UNCC honors Rodgers Builders CEO - Business First of Columbus:
http://www.superlinksworld.com/authors/author-1173.html
The Charlotte-based company has worked on several university including the Barnhardt StudentActivity Center, Irwin Belk Tracmk and Field Center, Lynch Residence Hall and the Bioinformaticw Research Center. Rodgers Builders also is the construction managerd onthe university’s new, $50.4 milliob Center City Building project that is slated to open in the fall of 2011. A groundbreakinfg ceremony was held in April for the classroom building at the corner of Ninth and Brevare streets inuptown “What sets Pat apart from most is her she remains personally invested in the institutions and organizations she touchees long after her formal involvement has says Philip Dubois, UNC Charlotte chancellor.
“Her commitment to the bettermengt of our community extends to her business In fact, Rodgers Builders has been hailed time and again as the epitomd of civic-minded business.” Rodgers is also chair of the Charlottd Symphony board and will assumew the chairmanship of the Charlotte Chambetr board in 2011. The universith established the Distinguished Service Awardin 1987. It honors individuals who have providede outstanding leadership and service to the Charlotte community and to the advancement ofUNC Charlotte.
Rodgerds was honored Tuesday during a luncheon at the UNC Charlotte isthe fourth-largesft campus among the 17 institutions of the UNC It is the largest institution of higher educatiob in the Charlotte region, offering doctoral, master’s and bachelor’s Fall 2008 enrollment was 23,300, including nearlyu 5,000 graduate students.
The Charlotte-based company has worked on several university including the Barnhardt StudentActivity Center, Irwin Belk Tracmk and Field Center, Lynch Residence Hall and the Bioinformaticw Research Center. Rodgers Builders also is the construction managerd onthe university’s new, $50.4 milliob Center City Building project that is slated to open in the fall of 2011. A groundbreakinfg ceremony was held in April for the classroom building at the corner of Ninth and Brevare streets inuptown “What sets Pat apart from most is her she remains personally invested in the institutions and organizations she touchees long after her formal involvement has says Philip Dubois, UNC Charlotte chancellor.
“Her commitment to the bettermengt of our community extends to her business In fact, Rodgers Builders has been hailed time and again as the epitomd of civic-minded business.” Rodgers is also chair of the Charlottd Symphony board and will assumew the chairmanship of the Charlotte Chambetr board in 2011. The universith established the Distinguished Service Awardin 1987. It honors individuals who have providede outstanding leadership and service to the Charlotte community and to the advancement ofUNC Charlotte.
Rodgerds was honored Tuesday during a luncheon at the UNC Charlotte isthe fourth-largesft campus among the 17 institutions of the UNC It is the largest institution of higher educatiob in the Charlotte region, offering doctoral, master’s and bachelor’s Fall 2008 enrollment was 23,300, including nearlyu 5,000 graduate students.
Tuesday, September 7, 2010
Health care reform could prove costly for some businesses - Portland Business Journal:
http://www.freewebsitedirectory.com/authors/author-7139.html
But some business groups fear that this goal migh not be achieved in the legislation now movingthrougnh Congress. They’re afraid the bill being markexd up this month by theSenate Education, Labor and Pensions Committee won’t do enough to control health care costss and that it will go too far in imposingy stiff new insurance requirements — including minimum coverage levels on employers. They also worry that includinga government-run plan as an optiobn in new insurance exchanges would lead hospitals and doctorss to charge private insurers more for their serviceas to compensate for underpaymentd they would receive from the publicv plan.
The has e-mailed its urging them to oppose the Senat eHELP Committee’s bill, calling it “qa dangerous proposal.” James Gelfand, the chamber’s senior managet of health policy, said he is optimistic that the Senatd ultimately won’t go along with a provision that calls for a government-appointe board to decide what level of benefitw must be included in insurance plans. If that provision is not many employers likely wouldr face higher insurance costs becausde senators look atthe benefits-rich plan now offered to federalo employees as the “gold standard” for health care he said.
Now is the time for businesses to demand changez inthe bill, including striking a requirementy for employers to provide insurancer to their workers, he said. Many small businesses simply can’t afford that, the chamber contends. “We need healt h reform,” Gelfand said. But if the bill isn’t fixed, “I don’t know how we could possibluy support it.” Business groups are hoping the Senated Finance Committee will producelegislation that’s friendlietr to employers.
The prospect of healtjh care reform raising costs for smalpl businessesis “a legitimate fear,” said John Arensmeyer, CEO of Smalkl Business Majority, an organization that believesw employers should provide insurance to theidr workers. But if done correctly, health care reform woulrd save smallbusinesses money, he said. A stud y commissioned by the organization founxd that businesses with fewer than 100 employees could save as muchas $855 billion in the next 10 years if health care reformm is enacted, compared with what they would pay for health insurancer if the system isn’t reformed.
The conducted by economist Jonathan Gruber, assumes that Congres s will require all but the smallest firms to provid health insurance to their employees or pay a fee to thefederap government, based on their size. It also assumes that Congresx will provide tax credits to smalo businesses to help them pay for thecoverage — a provisionn that is included in the Senatr HELP Committee’s bill. “With a strongg credit, small businesses can be a big winner in this Gruber said. Todd McCracken, president of the , said it is “not yet clear” whether small businesses will be betterr off after health care reform than theyare now.
Providingy tax credits or other subsidies to small businesses for insurance coverageecould “create all kinds of weird incentivese and disincentives” for companies, he said. Basingb the subsidies on the size of abusinesd isn’t a good solution because some smalk businesses — a law firm, for example — can be quitde profitable, he said. Focusing on low-wage businesses mighyt not be fair either because that encourages companiese to pay low he said. “Whatever you subsidize, you get more he said.
But some business groups fear that this goal migh not be achieved in the legislation now movingthrougnh Congress. They’re afraid the bill being markexd up this month by theSenate Education, Labor and Pensions Committee won’t do enough to control health care costss and that it will go too far in imposingy stiff new insurance requirements — including minimum coverage levels on employers. They also worry that includinga government-run plan as an optiobn in new insurance exchanges would lead hospitals and doctorss to charge private insurers more for their serviceas to compensate for underpaymentd they would receive from the publicv plan.
The has e-mailed its urging them to oppose the Senat eHELP Committee’s bill, calling it “qa dangerous proposal.” James Gelfand, the chamber’s senior managet of health policy, said he is optimistic that the Senatd ultimately won’t go along with a provision that calls for a government-appointe board to decide what level of benefitw must be included in insurance plans. If that provision is not many employers likely wouldr face higher insurance costs becausde senators look atthe benefits-rich plan now offered to federalo employees as the “gold standard” for health care he said.
Now is the time for businesses to demand changez inthe bill, including striking a requirementy for employers to provide insurancer to their workers, he said. Many small businesses simply can’t afford that, the chamber contends. “We need healt h reform,” Gelfand said. But if the bill isn’t fixed, “I don’t know how we could possibluy support it.” Business groups are hoping the Senated Finance Committee will producelegislation that’s friendlietr to employers.
The prospect of healtjh care reform raising costs for smalpl businessesis “a legitimate fear,” said John Arensmeyer, CEO of Smalkl Business Majority, an organization that believesw employers should provide insurance to theidr workers. But if done correctly, health care reform woulrd save smallbusinesses money, he said. A stud y commissioned by the organization founxd that businesses with fewer than 100 employees could save as muchas $855 billion in the next 10 years if health care reformm is enacted, compared with what they would pay for health insurancer if the system isn’t reformed.
The conducted by economist Jonathan Gruber, assumes that Congres s will require all but the smallest firms to provid health insurance to their employees or pay a fee to thefederap government, based on their size. It also assumes that Congresx will provide tax credits to smalo businesses to help them pay for thecoverage — a provisionn that is included in the Senatr HELP Committee’s bill. “With a strongg credit, small businesses can be a big winner in this Gruber said. Todd McCracken, president of the , said it is “not yet clear” whether small businesses will be betterr off after health care reform than theyare now.
Providingy tax credits or other subsidies to small businesses for insurance coverageecould “create all kinds of weird incentivese and disincentives” for companies, he said. Basingb the subsidies on the size of abusinesd isn’t a good solution because some smalk businesses — a law firm, for example — can be quitde profitable, he said. Focusing on low-wage businesses mighyt not be fair either because that encourages companiese to pay low he said. “Whatever you subsidize, you get more he said.
Sunday, September 5, 2010
David Archuleta Performing At The 2010 Jerry Lewis MDA Telethon - DisneyDreaming.com
http://naturesnestfarm.com/index_Page872.htm
David Archuleta Performing At The 2010 Jerry Lewis MDA Telethon DisneyDreaming.com David Archuleta will be performing at the 2010 Jerry Lewis MDA Telethon being held on Monday, September 6th. David took to Twitter to let his fans know the ... |
Saturday, September 4, 2010
Man to be arraigned in nonprofit fraud - Boston Business Journal:
http://rollyson.net/resources/group-meet.html
William O’Brien, 58, of Framingham is chargedd with 11 counts of larcenyover $250, two counts of larcen by continuous scheme and five counts of failurwe to file income tax returns. In October the AG’s office launched an investigationafter O’Brien’s allegerd activities were reported by the nonprofiyt organization, which was not identified. O’Brien had been hirede by the nonprofit to handles variousaccounting chores.
The nonprofit eventually discoveredthat O’Brieh had allegedly been diverting paymentw from the corporate account of the nonprofit’sx account, to another account in his O’Brien allegedly used the money for his own personapl use, including to buying items such as tickets to sporting events. He is set to be arraigned in Middlesed Superior Courtthis week.
William O’Brien, 58, of Framingham is chargedd with 11 counts of larcenyover $250, two counts of larcen by continuous scheme and five counts of failurwe to file income tax returns. In October the AG’s office launched an investigationafter O’Brien’s allegerd activities were reported by the nonprofiyt organization, which was not identified. O’Brien had been hirede by the nonprofit to handles variousaccounting chores.
The nonprofit eventually discoveredthat O’Brieh had allegedly been diverting paymentw from the corporate account of the nonprofit’sx account, to another account in his O’Brien allegedly used the money for his own personapl use, including to buying items such as tickets to sporting events. He is set to be arraigned in Middlesed Superior Courtthis week.
Thursday, September 2, 2010
Congress considers jail for biotech exec crimes - San Francisco Business Times:
http://www.osnovanie.info/?page_id=4
The Drug Device and Accountability Act of 2008 would imposse as much asa $5 million fine and 20-year jail sentence upon waywar corporate executives. The bill was referred to the Committeson Health, Education, Labor and Pensions in late July. It is sponsoredd by Sens. Kennedy (D-Mass.) and Grassleuy (R-Iowa). The law, which wouldc amend the Federal Food, Drug, and Cosmetic Act, is intendeed to give federal officials more oversight in regulatint drugs and medical devicesmanufactured overseas.
But a lesser-knowhn section of the bill cracks down on life sciencde executives who certify false information about a drug or According tothe bill, if executives know “that a componeng of such certification is falsr or misleading,” they can be finedr between $1 million and $5 million and served from 10 to 20 yeards in prison. “The company is a faceless and it’s important to hold people accountablr rather thanthe corporation,” said Sidneg Wolfe, director of health research at the D.C.-based nonprofit Public Citizen. “(The bill) is the kind of thinb that will make people in the industrymore honest.
” The legislationh is unique in that it allowsw the Food and Drug Administration to take actioj against individual executives and even impose jail sentences. If the bill regulators will have unprecedented authorityt to go after corporat e leaders as well astheir companies. As the act is enterin the legislative process, executives in the life science industry are only beginnintheir analysis. Yet those who have glancedd at the section on executive penalties say the termasare excessive.
Matt Gardner of the San Francisco-basedr BayBIO industry group, reminds that pharmaceuticap executives work in the most regulated industry in the and that measures are constantly being takejn to strengthen the drugcertification process. “s 20-year jail sentence seems a bit much,” said Consumer groups rebut with tales of the drug industrygone awry. Whils missing and forged certificatio information can lead to deatjhand injury, it can also cost consumersw money. Over the past five years, many suitsd have been filed againstthe Stamford, Conn.-basedr for falsifying information abouft painkiller OxyContin.
The company originally claimed OxyContin is uniquely effective at low and patents based on this false information blockecgeneric alternatives. Even though Purdue was found guilty ofmisrepresentintg information, consumer advocacy groups say executivew got off with a slap on the wrist. “Thr FDA has very little authoritt to impose civilmonetary penalties,” said Wolfe. “Even when top officialse pay fines, they are often small, and they don’t go to This means the company absorbs most of thepenalty — but when an entith takes in billions of dollarsx a year, it isn’t hard to pay expensive fines.
Some even argue that pharmaceutical companie can afford to strategically certifh incorrect information since there is no significant liability. The act is viewed as bipartisan, and the concepg of holding drug makers accountable is backed by many consumer groups. Yet most agree that the bill faces anuncertai future, given changes in the Senate, Housr and White House. Like other members of the bioscience community, BayBI O says it will keep its eye on the bill and wait to seehow President-elecft Obama’s administration affects life science policy. “There is good reasomn to be optimistic about the way Obam a will view the lifescienced sector,” said Gardner.
Should the bill make it out of he is confident thatthe industry’s voice will be “Kennedy and (Rep. Nancy) Pelosi (D-S.F.) have alwayss been supportive ofthe life-science and they realize the importance of innovation and entrepreneurship,” said “If the bill moves forward, I’km sure they will be open to feedback.”
The Drug Device and Accountability Act of 2008 would imposse as much asa $5 million fine and 20-year jail sentence upon waywar corporate executives. The bill was referred to the Committeson Health, Education, Labor and Pensions in late July. It is sponsoredd by Sens. Kennedy (D-Mass.) and Grassleuy (R-Iowa). The law, which wouldc amend the Federal Food, Drug, and Cosmetic Act, is intendeed to give federal officials more oversight in regulatint drugs and medical devicesmanufactured overseas.
But a lesser-knowhn section of the bill cracks down on life sciencde executives who certify false information about a drug or According tothe bill, if executives know “that a componeng of such certification is falsr or misleading,” they can be finedr between $1 million and $5 million and served from 10 to 20 yeards in prison. “The company is a faceless and it’s important to hold people accountablr rather thanthe corporation,” said Sidneg Wolfe, director of health research at the D.C.-based nonprofit Public Citizen. “(The bill) is the kind of thinb that will make people in the industrymore honest.
” The legislationh is unique in that it allowsw the Food and Drug Administration to take actioj against individual executives and even impose jail sentences. If the bill regulators will have unprecedented authorityt to go after corporat e leaders as well astheir companies. As the act is enterin the legislative process, executives in the life science industry are only beginnintheir analysis. Yet those who have glancedd at the section on executive penalties say the termasare excessive.
Matt Gardner of the San Francisco-basedr BayBIO industry group, reminds that pharmaceuticap executives work in the most regulated industry in the and that measures are constantly being takejn to strengthen the drugcertification process. “s 20-year jail sentence seems a bit much,” said Consumer groups rebut with tales of the drug industrygone awry. Whils missing and forged certificatio information can lead to deatjhand injury, it can also cost consumersw money. Over the past five years, many suitsd have been filed againstthe Stamford, Conn.-basedr for falsifying information abouft painkiller OxyContin.
The company originally claimed OxyContin is uniquely effective at low and patents based on this false information blockecgeneric alternatives. Even though Purdue was found guilty ofmisrepresentintg information, consumer advocacy groups say executivew got off with a slap on the wrist. “Thr FDA has very little authoritt to impose civilmonetary penalties,” said Wolfe. “Even when top officialse pay fines, they are often small, and they don’t go to This means the company absorbs most of thepenalty — but when an entith takes in billions of dollarsx a year, it isn’t hard to pay expensive fines.
Some even argue that pharmaceutical companie can afford to strategically certifh incorrect information since there is no significant liability. The act is viewed as bipartisan, and the concepg of holding drug makers accountable is backed by many consumer groups. Yet most agree that the bill faces anuncertai future, given changes in the Senate, Housr and White House. Like other members of the bioscience community, BayBI O says it will keep its eye on the bill and wait to seehow President-elecft Obama’s administration affects life science policy. “There is good reasomn to be optimistic about the way Obam a will view the lifescienced sector,” said Gardner.
Should the bill make it out of he is confident thatthe industry’s voice will be “Kennedy and (Rep. Nancy) Pelosi (D-S.F.) have alwayss been supportive ofthe life-science and they realize the importance of innovation and entrepreneurship,” said “If the bill moves forward, I’km sure they will be open to feedback.”
Subscribe to:
Posts (Atom)